siRNA therapy reduces triglycerides in clients with unusual health condition

.INVESTIGATION FEATURE.19 September 2024.

Plozasiran lowered triglyceride levels by 80% and also reduced the danger of pancreatitis in patients along with relentless chylomicronemia, with or even without a hereditary medical diagnosis.